Vol 80, No 2 (2022)
Short communication
Published online: 2021-12-16
HIV-infected patients on combined antiretroviral treatment had a similar level of arterial stiffness to the patients with ST-segment elevation myocardial infarction
Abstract
Not available
References
- Chow FC, Regan S, Feske S, et al. Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr. 2012; 60(4): 351–358.
- Badejo OA, Chang CC, So-Armah KA, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013; 173(8): 614–622.
- Xu Y, Arora RC, Hiebert BM, et al. Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2014; 15(7): 736–746.
- Kikuya M, Asayama K, Ohkubo T. Blood pressure variability and arterial stiffness parameters derived from ambulatory blood pressure monitoring. Kardiol Pol. 2019; 77(5): 509–514.
- Nadel J, O'Dwyer E, Emmanuel S, et al. High-risk coronary plaque, invasive coronary procedures, and cardiac events among HIV-positive individuals and matched controls. J Cardiovasc Comput Tomogr. 2016; 10(5): 391–397.
- EACS Treatment Guidelines version 10.1 Available online: www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html. [Access: November 2020].
- Triant VA, Perez J, Regan S, et al. Cardiovascular risk prediction functions underestimate risk in HIV infection. Circulation. 2018; 137(21): 2203–2214.
- Krikke M, Hoogeveen RC, Hoepelman AIM, et al. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models. HIV Med. 2016; 17(4): 289–297.
- Centers for Disease Control and Prevention: National Center for Health Statistics - National Health Interview Survey. Available online: www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm. [Access: November 2021].
- Knobel H, Domingo P, Suarez-Lozano I, et al. Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain. Enferm Infecc Microbiol Clin. 2019; 37(6): 373–379.
- Alvi RM, Neilan AM, Tariq N, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV and heart failure. J Am Coll Cardiol. 2018; 72(5): 518–530.
- Morris PB, Ference BA, Jahangir E, et al. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. J Am Coll Cardiol. 2015; 66(12): 1378–1391.
